Regulation of focal adhesion kinase activation, breast cancer cell motility, and amoeboid invasion by the rhoa guanine nucleotide exchange factor net1

Molecular and Cellular Biology

Volumn 33, Issue 14, 2013, Pages 2773-2786

  Carr, Heather S ^a   Zuo, Yan ^a   Oh, Wonkyung ^a   Frost, Jeffrey A ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; FOCAL ADHESION KINASE; ISOPROTEIN; LYSOPHOSPHATIDIC ACID; MATRIGEL; MATRIX METALLOPROTEINASE 14; MYOSIN LIGHT CHAIN; NET1 PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG;

AMOEBOID MOVEMENT; ARTICLE; BREAST CANCER; CANCER CELL; CELL MATURATION; CELL MIGRATION; CELL MOTILITY; CELL MOTION; CHEMOTAXIS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; EXTRACELLULAR MATRIX; FEMALE; FOCAL ADHESION; GENE SILENCING; HOMEOSTASIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

BREAST NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL SHAPE; CHEMOTAXIS; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; FEMALE; FOCAL ADHESION KINASE 1; FOCAL ADHESIONS; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; LYSOPHOSPHOLIPIDS; MYOSIN LIGHT CHAINS; NEOPLASM INVASIVENESS; ONCOGENE PROTEINS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN ISOFORMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT; RHOA GTP-BINDING PROTEIN;

EID: 84880659265     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00175-13     Document Type: Article

References (60)

1. Fritz G, Brachetti C, Bahlmann F, Schmidt M, Kaina B. 2002. Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters. Br. J. Cancer 87:635-644.
2. Fritz G, Just I, Kaina B. 1999. Rho GTPases are over-expressed in human tumors. Int. J. Cancer 81:682-687.
3. Jaffe AB, Hall A. 2005. Rho GTPases: biochemistry and biology. Annu. Rev. Cell Dev. Biol. 21:247-269.
4. Wheeler AP, Ridley AJ. 2004. Why three Rho proteins? RhoA, RhoB, RhoC, and cell motility. Exp. Cell Res. 301:43-49.
5. Burridge K, Wennerberg K. 2004. Rho and Rac take center stage. Cell 116:167-179.
6. Olson MF, Sahai E. 2009. The actin cytoskeleton in cancer cell motility. Clin. Exp. Metastasis 26:273-287.
7. Ridley AJ. 2011. Life at the leading edge. Cell 145:1012-1022.
8. Friedl P, Wolf K. 2010. Plasticity of cell migration: a multiscale tuning model. J. Cell Biol. 188:11-19.
9. Sanz-Moreno V, Marshall CJ. 2010. The plasticity of cytoskeletal dynamics underlying neoplastic cell migration. Curr. Opin. Cell Biol. 22:690-696.
10. Narumiya S, Tanji M, Ishizaki T. 2009. Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion. Cancer Metastasis Rev. 28:65-76.
11. Meller N, Merlot S, Guda C. 2005. CZH proteins: a new family of Rho-GEFs. J. Cell Sci. 118:4937-4946.
12. Rossman KL, Der CJ, Sondek J. 2005. GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors. Nat. Rev. Mol. Cell Biol. 6:167-180.
13. Chan AM, Takai S, Yamada K, Miki T. 1996. Isolation of a novel oncogene, NET1, from neuroepithelioma cells by expression cDNA cloning. Oncogene 12:1259-1266.
14. Alberts AS, Treisman R. 1998. Activation of RhoA and SAPK/JNK signalling pathways by the RhoA-speciFfic exchange factor mNET1. EMBO J. 17:4075-4085.
15. Srougi MC, Burridge K. 2011. The nuclear guanine nucleotide exchange factors Ect2 and Net1 regulate RhoB-mediated cell death after DNA damage. PLoS One 6:e17108. doi:10.1371/journal.pone.0017108.
16. Qin H, Carr HS, Wu X, Muallem D, Tran NH, Frost JA. 2005. Characterization of the biochemical and transforming properties of the neuroepithelial transforming protein 1. J. Biol. Chem. 280:7603-7613.
17. Schmidt A, Hall A. 2002. The Rho exchange factor Net1 is regulated by nuclear sequestration. J. Biol. Chem. 277:14581-14588.
18. Papadimitriou E, Vasilaki E, Vorvis C, Iliopoulos D, Moustakas A, Kardassis D, Stournaras C. 2012. Differential regulation of the two RhoA-specific GEF isoforms Net1/Net1A by TGF-beta and miR-24: role in epithelial-to-mesenchymal transition. Oncogene 31:2862-2875.
19. Shen X, Li J, Hu PP, Waddell D, Zhang J, Wang XF. 2001. The activity of guanine exchange factor NET1 is essential for transforming growth factor-beta-mediated stress fiber formation. J. Biol. Chem. 276:15362-15368.
20. Carr HS, Morris CA, Menon S, Song EH, Frost JA. 2013. Rac1 controls the subcellular localization of the Rho guanine nucleotide exchange factor Net1A to regulate focal adhesion formation and cell spreading. Mol. Cell. Biol. 33:622-634.
21. Dutertre M, Gratadou L, Dardenne E, Germann S, Samaan S, Lidereau R, Driouch K, de la Grange P, Auboeuf D. 2010. Estrogen regulation and physiopathologic significance of alternative promoters in breast cancer. Cancer Res. 70:3760-3770.
22. Leyden J, Murray D, Moss A, Arumuguma M, Doyle E, McEntee G, O'Keane C, Doran P, MacMathuna P. 2006. Net1 and Myeov: computationally identified mediators of gastric cancer. Br. J. Cancer 94:1204-1212.
23. Shen SQ, Li K, Zhu N, Nakao A. 2008. Expression and clinical significance of NET-1 and PCNA in hepatocellular carcinoma. Med. Oncol. 25:341-345.
24. Tu Y, Lu J, Fu J, Cao Y, Fu G, Kang R, Tian X, Wang B. 2010. Over-expression of neuroepithelial-transforming protein 1 confers poor prognosis of patients with gliomas. Jpn. J. Clin. Oncol. 40:388-394.
25. Gilcrease MZ, Kilpatrick SK, Woodward WA, Zhou X, Nicolas MM, Corley LJ, Fuller GN, Tucker SL, Diaz LK, Buchholz TA, Frost JA. 2009. Coexpression of alpha6beta4 integrin and guanine nucleotide exchange actor Net1 identifies node-positive breast cancer patients at high risk for distant metastasis. Cancer Epidemiol. Biomarkers Prev. 18:80-86.
26. Murray D, Horgan G, MacMathuna P, Doran P. 2008. NET1-mediated RhoA activation facilitates lysophosphatidic acid-induced cell migration and invasion in gastric cancer. Br. J. Cancer 99:1322-1329.
27. Carr HS, Cai C, Keinanen K, Frost JA. 2009. Interaction of the RhoA exchange factor Net1 with Discs Large Homolog 1 protects it from proteasome mediated degradation and potentiates Net1 activity. J. Biol. Chem. 284:24269-24280.
28. Frost JA, Xu S, Hutchison MR, Marcus S, Cobb MH. 1996. Actions of Rho family small G proteins and p21-activated protein kinases on mitogen-activated protein kinase family members. Mol. Cell. Biol. 16:3707-3713.
29. Hooper S, Marshall JF, Sahai E. 2006. Tumor cell migration in three dimensions. Methods Enzymol. 406:625-643.
30. Scott RW, Hooper S, Crighton D, Li A, Konig I, Munro J, Trivier E, Wickman G, Morin P, Croft DR, Dawson J, Machesky L, Anderson KI, Sahai EA, Olson MF. 2010. LIM kinases are required for invasive path generation by tumor and tumor-associated stromal cells. J. Cell Biol. 191: 169-185.
31. Iwanicki MP, Vomastek T, Tilghman RW, Martin KH, Banerjee J, Wedegaertner PB, Parsons JT. 2008. FAK, PDZ-RhoGEF and ROCKII cooperate to regulate adhesion movement and trailing-edge retraction in fibroblasts. J. Cell Sci. 121:895-905.
32. Amano M, Ito M, Kimura K, Fukata Y, Chihara K, Nakano T, Matsuura Y, Kaibuchi K. 1996. Phosphorylation and activation of myosin by Rhoassociated kinase (Rho-kinase). J. Biol. Chem. 271:20246-20249.
33. Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M, Yamamori B, Feng J, Nakano T, Okawa K, Iwamatsu A, Kaibuchi K. 1996. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 273:245-248.
34. Garcia-Mata R, Dubash AD, Sharek L, Carr HS, Frost JA, Burridge K. 2007. The nuclear RhoA exchange factor Net1 interacts with proteins of the Dlg family, affects their localization, and influences their tumor suppressor activity. Mol. Cell. Biol. 27:8683-8697.
35. Worthylake RA, Lemoine S, Watson JM, Burridge K. 2001. RhoA is required for monocyte tail retraction during transendothelial migration. J. Cell Biol. 154:147-160.
36. Yoshinaga-Ohara N, Takahashi A, Uchiyama T, Sasada M. 2002. Spatiotemporal regulation of moesin phosphorylation and rear release by Rho and serine/threonine phosphatase during neutrophil migration. Exp. Cell Res. 278:112-122.
37. Cohen LA, Guan JL. 2005. Mechanisms of focal adhesion kinase regulation. Curr. Cancer Drug Targets 5:629-643.
38. Mitra SK, Schlaepfer DD. 2006. Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr. Opin. Cell Biol. 18:516-523.
39. Lim ST, Chen XL, Lim Y, Hanson DA, Vo TT, Howerton K, Larocque N, Fisher SJ, Schlaepfer DD, Ilic D. 2008. Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation. Mol. Cell 29:9-22.
40. Hildebrand JD, Schaller MD, Parsons JT. 1993. Identiification of sequences required for the efficient localization of the focal adhesion kinase, pp125FAK, to cellular focal adhesions. J. Cell Biol. 123:993-1005.
41. Katz BZ, Miyamoto S, Teramoto H, Zohar M, Krylov D, Vinson C, Gutkind JS, Yamada KM. 2002. Direct transmembrane clustering and cytoplasmic dimerization of focal adhesion kinase initiates its tyrosine phosphorylation. Biochim. Biophys. Acta 1592:141-152.
42. Toutant M, Costa A, Studler JM, Kadare G, Carnaud M, Girault JA. 2002. Alternative splicing controls the mechanisms of FAK autophosphorylation. Mol. Cell. Biol. 22:7731-7743.
43. Schaller MD, Hildebrand JD, Shannon JD, Fox JW, Vines RR, Parsons JT. 1994. Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src. Mol. Cell. Biol. 14:1680-1688.
44. Sieg DJ, Hauck CR, Schlaepfer DD. 1999. Required role of focal adhesion kinase (FAK) for integrin-stimulated cell migration. J. Cell Sci. 112:2677-2691.
45. Tachibana K, Sato T, D'Avirro N, Morimoto C. 1995. Direct association of pp125FAK with paxillin, the focal adhesion-targeting mechanism of pp125FAK. J. Exp. Med. 182:1089-1099.
46. Dobrosotskaya IY. 2001. Identification of mNET1 as a candidate ligand for the first PDZ domain of MAGI-1. Biochem. Biophys. Res. Commun. 283:969-975.
47. Vessichelli M, Ferravante A, Zotti T, Reale C, Scudiero I, Picariello G, Vito P, Stilo R. 2012. Neuroepithelial transforming gene 1 (Net1) binds to caspase activation and recruitment domain (CARD)- and membraneassociated guanylate kinase-like domain-containing (CARMA) proteins and regulates nuclear factor kappaB activation. J. Biol. Chem. 287:13722-13730.
48. Sahai E, Marshall CJ. 2003. Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nat. Cell Biol. 5:711-719.
49. Wolf K, Mazo I, Leung H, Engelke K, von Andrian UH, Deryugina EI, Strongin AY, Brocker EB, Friedl P. 2003. Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J. Cell Biol. 160:267-277.
50. Sanz-Moreno V, Gadea G, Ahn J, Paterson H, Marra P, Pinner S, Sahai E, Marshall CJ. 2008. Rac activation and inactivation control plasticity of tumor cell movement. Cell 135:510-523.
51. Jiang WG, Davies G, Martin TA, Parr C, Watkins G, Mason MD, Mansel RE. 2006. Expression of membrane type-1 matrix metalloproteinase, MT1-MMP in human breast cancer and its impact on invasiveness of breast cancer cells. Int. J. Mol. Med. 17:583-590.
52. Wolf K, Wu YI, Liu Y, Geiger J, Tam E, Overall C, Stack MS, Friedl P. 2007. Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion. Nat. Cell Biol. 9:893-904.
53. Wang Q, Liu M, Kozasa T, Rothstein JD, Sternweis PC, Neubig RR. 2004. Thrombin and lysophosphatidic acid receptors utilize distinct rho-GEFs in prostate cancer cells. J. Biol. Chem. 279:28831-28834.
54. Yamada T, Ohoka Y, Kogo M, Inagaki S. 2005. Physical and functional interactions of the lysophosphatidic acid receptors with PDZ domaincontaining Rho guanine nucleotide exchange factors (RhoGEFs). J. Biol. Chem. 280:19358-19363.
55. Chrzanowska-Wodnicka M, Burridge K. 1996. Rho-stimulated contractility drives the formation of stress fibers and focal adhesions. J. Cell Biol. 133:1403-1415.
56. Lim Y, Lim ST, Tomar A, Gardel M, Bernard-Trifilo JA, Chen XL, Uryu SA, Canete-Soler R, Zhai J, Lin H, Schlaepfer WW, Nalbant P, Bokoch G, Ilic D, Waterman-Storer C, Schlaepfer DD. 2008. PyK2 and FAK connections to p190Rho guanine nucleotide exchange factor regulate RhoA activity, focal adhesion formation, and cell motility. J. Cell Biol. 180:187-203.
57. Zhai J, Lin H, Nie Z, Wu J, Canete-Soler R, Schlaepfer WW, Schlaepfer DD. 2003. Direct interaction of focal adhesion kinase with p190RhoGEF.J. Biol. Chem. 278:24865-24873.
58. Fraley SI, Feng Y, Krishnamurthy R, Kim DH, Celedon A, Longmore GD, Wirtz D. 2010. A distinctive role for focal adhesion proteins in three-dimensional cell motility. Nat. Cell Biol. 12:598-604.
59. Sabeh F, Shimizu-Hirota R, Weiss SJ. 2009. Protease-dependent versus -independent cancer cell invasion programs: three-dimensional amoeboid movement revisited. J. Cell Biol. 185:11-19.
60. Nakaya Y, Sukowati EW, Wu Y, Sheng G. 2008. RhoA and microtubule dynamics control cell-basement membrane interaction in EMT during gastrulation. Nat. Cell Biol. 10:765-775.